Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Maisonneuve-Rosemont Hospital Research Center, Montreal, QC, Canada.
J Intern Med. 2016 Sep;280(3):276-86. doi: 10.1111/joim.12502. Epub 2016 Apr 20.
The cornea is the transparent front part of the eye that transmits light to the back of the eye to generate vision. Loss of corneal transparency, if irreversible, leads to severe vision loss or blindness. For decades, corneal transplantation using human donor corneas has been the only option for treating corneal blindness. Despite recent improvement in surgical techniques, donor cornea transplantation remains plagued by risks of suboptimal optical results and visual acuity, immune rejection and eventually graft failure. Furthermore, the demand for suitable donor corneas is increasing faster than the number of donors, leaving thousands of curable patients untreated worldwide. Here, we critically review the state of the art of biomaterials for corneal regeneration. However, the lessons learned from the use of the cornea as a disease model will allow for extension of the biomaterials and techniques for regeneration of more complex organs such as the heart.
角膜是眼睛的透明前部,它将光线传输到眼睛后部以产生视觉。如果角膜的透明度不可逆转地丧失,就会导致严重的视力丧失或失明。几十年来,使用人类供体角膜进行角膜移植一直是治疗角膜盲的唯一选择。尽管最近手术技术有所改进,但供体角膜移植仍然存在光学效果和视力不佳、免疫排斥和最终移植物失败的风险。此外,对合适供体角膜的需求增长速度超过了供体数量,导致全球数千名可治愈的患者未得到治疗。在这里,我们批判性地回顾了用于角膜再生的生物材料的最新技术。然而,从将角膜用作疾病模型中获得的经验教训将使生物材料和技术得以扩展,从而再生更复杂的器官,如心脏。